The sale is pre-planned under a 10b5-1 program and is small relative to market cap. Monitor for any acceleration of insider selling beyond the scheduled plan amounts, which could signal a change in sentiment.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $72.00entry
- T+1 · 7d ago −1.85%α −1.37% · $70.67
- T+5 · due 13h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Stephen P. Carey, an officer of ANI Pharmaceuticals, filed a Form 144 notice of intent to sell 8,550 shares of common stock with an approximate market value of $613,120. The shares were acquired via restricted stock awards vesting between March and April 2021. The sale is planned for execution on Nasdaq, and the filing references a Rule 10b5-1 trading plan established on March 6, 2026.
Key Facts
- Reporting owner: Stephen P. Carey, an officer of ANI Pharmaceuticals
- Shares to be sold: 8,550 shares of common stock
- Approximate value: $613,120.50
- Shares acquired via restricted stock awards vesting 03/31/2021 through 04/10/2021
- Sale intended for execution on Nasdaq on 10/29/2026
- Filing references a Rule 10b5-1 trading plan dated 03/06/2026
- Prior 10b5-1 sales noted: 2,850 shares on 09/29/2026 ($208,045) and 2,850 shares on 08/31/2026 ($207,475)
Financial Impact
Proposed sale of $613K worth of stock, representing approximately 0.04% of ANIP's $1.6B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- Insider selling under a 10b5-1 plan is routine and not necessarily indicative of negative outlook
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010479 |
| Document: 0001950047-26-010479-index.html | 0001950047-26-010479 |
| Document: 0001950047-26-010479.txt | 0001950047-26-010479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 5, 2026 today | 8-K | $73.00 | awaiting T+60 | awaiting T+60 | $69.62 (−4.63%) |
Nov 5, 2026 today | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
Nov 5, 2026 today | Press Release | $73.22 | awaiting T+60 | awaiting T+60 | $69.62 (−4.92%) |
Nov 5, 2026 today | Press Release | $73.22 | awaiting T+60 | awaiting T+60 | $69.62 (−4.92%) |
Nov 5, 2026 today | Press Release | $73.22 | awaiting T+60 | awaiting T+60 | $69.62 (−4.92%) |
Oct 29, 2026 7d ago | 144 | $72.00 | awaiting T+60 | awaiting T+60 | $69.62 (−3.31%) |
Oct 16, 2026 20d ago | Insider Cluster | $72.56 | awaiting T+60 | awaiting T+60 | $69.62 (+4.05%) |
Sep 23, 2026 6w ago | Press Release | $74.43 | awaiting T+60 | awaiting T+60 | $69.62 (−6.46%) |
Sep 16, 2026 7w ago | Insider Cluster | $75.39 | awaiting T+60 | awaiting T+60 | $69.62 (−7.65%) |
Sep 14, 2026 7w ago | Insider Cluster | $72.11 | awaiting T+60 | awaiting T+60 | $69.62 (−3.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers